Seminars
The Department of Chemistry and Chemical Biology seminar series is open to anyone on the Stevens campus. The seminars will be in person or live webcast via Zoom. Click here to join.
February 10 1 - 2 p.m. Peirce 116 | John A. McCauley, Ph.D., Senior Director, Medicinal Chemistry, Merck, West Point, PA Dual Plasmepsin IX/X Inhibitors: An Antimalarial Drug Discovery Collaboration |
February 24 1 - 2 p.m. Peirce 116 | Hong Li, Director, Center for Advanced Proteomics, Department of Microbiology & Biochemistry, Rutgers Biomedical & Health Sciences, Newark, NJ How to Partner with Proteomics/MS Cores to Advance your Basic and Translational Research Goals? |
Past Seminar Series Speakers
View speakers and seminar topics for the previous two years.
Dr. Rumin Zhang, VP, Head of Biochemistry, Volastra Therapeutics
Evolution of the HIV Treatment Landscape
Dr. Mikołaj Zaborowski, Poznan University of Medical Sciences, Poznan, Poland
Circles in a Bubble – Exploring the Diagnostic Potential of CircRNAs from Extracellular Vesicles in Ovarian Cancer
Dr. Rick Monsma, Senior Vice President, Scientific Operations, New York Stem Cell Foundation Research Institute, New York, NY
The New York Stem Cell Foundation: Leveraging Stem Cell Technologies to Advance Disease Treatments, Regenerative Medicine and Bioengineering
Dr. Rudi Fasan, Department of Chemistry, University of Rochester, Rochester, NY
Biocatalysts for New-to-Nature Reactions: Engineered Carbene Transferases for Selective Carbon-Carbon Bond Formation
Dr. Simarna Kaur, Associate Director, World Without Disease Accelerator, Janssen, Johnson & Johnson
Inflamm-Aging in Skin: Evaluating the Mechanisms of Action and Functional Impact
Dr. Sunny Choe, Sr. Medical Scientist, HIV Medical Affairs, Gilead Sciences, Inc
Evolution of the HIV Treatment Landscape
Dr. Jinrui Xu, Associate Research Scientist, Dept. of Molecular Biophysics and Biochemistry, School of Medicine, Yale University
Using Genomic Data to Discover Gene Pathogenicity Guided by Evolutionary Analyses
Dr. Adam Weinglass, Executive Director, Screening & Compound Profiling/Quantitative Biosciences, Merck & Co. and Dr. Andrea Peier, Senior Director, Screening & Compound Profiling/Quantitative Biosciences, Merck & Co.
Accelerating Early Drug Discovery with High-Throughput Screening (HTS) & Hit-to-Lead Using a Refreshed Biochemical & Cellular Toolbox
Dr. Shibiao Wan, Research Scientist, St. Jude Children's Research Hospital, Memphis, TN
Machine Learning for Processing Large-Scale Biological Data
Dr. Shenglong Zhang, Associate Professor, Department of Biological & Chemical Sciences, New York Institute of Technology
Development of Next Generation Mass Spectrometry-Based De Novo RNA Sequencing For All Modifications
Dr. Isra Hassan, Senior Scientist, Novartis Institutes for Biomedical Research
Asymmetric Lactam Synthesis with a Monomeric Streptavidin Artificial Metalloenzyme
Dr. Yana Bromberg, Senior Scientist, Novartis Institutes for Biomedical Research
Microbiome Functionality as a Signature of the Environmental Conditions
Dr. Yingkai Zhang, Professor, Department of Chemistry, New York University
Integrating Machine Learning and Molecular Modeling for Drug Design
Professor Gary Martin, Adjunct Faculty, Stevens Institute of Technology
Getting Published: The View from an Editor’s Perspective
Dr. Michael P. Vergi, Associate Professor of Genetics, Rutgers University
Epigenomic Approaches to Deciphering Gastrointestinal Health and SARS-CoV-2-Related Gene Regulation
Dr. Ibarrola Recalde, Postdoctoral Research Associate at the Department of Chemical Engineering and Material Science
The Effects of Implementing Evidence-Based Pedagogies on Student Performance in a General Chemistry Course
Dr. Benjamin Tycko, HMH Center for Discovery and Innovation & School of Medicine at Seton Hall University
Cancer-Focused Applications Of Epigenome Mapping And Epigenetically Acting Drugs
Dr. Jounghyun Helen Lee, Associate Research Scientist in the Department of Biomedical Engineering at Columbia University
Emulating Early Atherosclerosis in a Vascular Microphysiological System Using Branched Tissue-Engineered Blood Vessels
Dr. Nicholas John Murgolo, Senior Principal Scientist, Merck Research Laboratories
Optimal in vitro Screening Methods for Inhibitors of SARS-CoV2: Consideration of Host Cell Lines and Tissues Permissive for Replication, Tropism, Entry and Propagation
Dr. Karen Akinsanya, Executive Vice President and Chief Biomedical Scientist, Schrodinger
Modernizing Drug Discovery and Development: Integrating Data and Decision Sciences
Dr. Lance Bruck, Vice President and Chairman, Gynecology & Women’s Health, Jersey City Medical Center
COVID-19 and Pregnancy
Dr. Alysson R. Muotri, Professor Director of the Stem Cell Program, UCSD School of Medicine
Use of Human Brain Organoids to Understand the Neurological Component of Covid-19